Nivolumab,Ipilimumab
BMS
['nivolumab', 'nivo', 'ipilimumab']
find david pinato &amp; antonio d'alessio in hall a to hear their research into neoadjuvant #immunotherapy with ipilimumab plus nivolumab &amp; the #tumour microenvironment: #crukfunded #asco23 
We're here to support our broad cancer research community of 4,000 scientists and clinicians. For general Cancer Research UK news & fundraising follow @CR_UK